SEARCH

SEARCH BY CITATION

References

  • Auffermann-Gretzinger, S., Lossos, I.S., Vayntrub, T.A., Leong, W., Grumet, F.C., Blume, K.G., Stockerl-Goldstein, K.E., Levy, R. & Shizuru, J.A. (2002) Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood, 99, 14421448.
  • Barber, L.D. & Madrigal, J.A. (2006) Exploiting beneficial alloreactive T cells. Vox Sanguinis, 91, 2027.
  • Baron, F., Baker, J.E., Storb, R., Gooley, T.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Heimfeld, S., Oparin, D., Zellmer, E., Radich, J.P., Grumet, F.C., Blume, K.G., Chauncey, T.R. & Little, M.T. (2004) Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood, 104, 22542262.
  • Baron, F., Maris, M.B., Sandmaier, B.M., Storer, B.E., Sorror, M., Diaconescu, R., Woolfrey, A.E., Chauncey, T.R., Flowers, M.E., Mielcarek, M., Maloney, D.G. & Storb, R. (2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Journal of Clinical Oncology, 23, 19932003.
  • Beatty, G.L., Smith, J.S., Reshef, R., Patel, K.P., Colligon, T.A., Vance, B.A., Frey, N.V., Johnson, F.B., Porter, D.L. & Vonderheide, R.H. (2009) Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation. Clinical and Cancer Research, 15, 49444953.
  • Buggins, A.G., Mufti, G.J., Salisbury, J., Codd, J., Westwood, N., Arno, M., Fishlock, K., Pagliuca, A. & Devereux, S. (2002) Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab. Blood, 100, 17151720.
  • Chakrabarti, S., Hale, G. & Waldmann, H. (2004) Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here? Transplantation Proceedings, 36, 12251227.
  • Chakraverty, R., Peggs, K., Chopra, R., Milligan, D.W., Kottaridis, P.D., Verfuerth, S., Geary, J., Thuraisundaram, D., Branson, K., Chakrabarti, S., Mahendra, P., Craddock, C., Parker, A., Hunter, A., Hale, G., Waldmann, H., Williams, C.D., Yong, K., Linch, D.C., Goldstone, A.H. & Mackinnon, S. (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood, 99, 10711078.
  • Childs, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E.J., Carter, C., Bahceci, E., Young, N.S. & Barrett, A.J. (1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood, 94, 32343241.
  • Collins, Jr, R.H., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H. & Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 15, 433444.
  • Cooper, M.A., Fehniger, T.A. & Caligiuri, M.A. (2001) The biology of human natural killer-cell subsets. Trends in Immunology, 22, 633640.
  • Dey, B.R., McAfee, S., Colby, C., Sackstein, R., Saidman, S., Tarbell, N., Sachs, D.H., Sykes, M. & Spitzer, T.R. (2003) Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation, 9, 320329.
  • Ho, A.Y., Pagliuca, A., Kenyon, M., Parker, J.E., Mijovic, A., Devereux, S. & Mufti, G.J. (2004) Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. Blood, 104, 16161623.
  • Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C. & Speck, B. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555562.
  • Kim, D.H., Kim, J.G., Sohn, S.K., Sung, W.J., Suh, J.S., Lee, K.S. & Lee, K.B. (2004) Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. British Journal of Haematology, 125, 217224.
  • Klangsinsirikul, P., Carter, G.I., Byrne, J.L., Hale, G. & Russell, N.H. (2002) Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood, 99, 25862591.
  • Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L. & Niederwieser, D. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86, 20412050.
  • Kumar, S., Chen, M.G., Gastineau, D.A., Gertz, M.A., Inwards, D.J., Lacy, M.Q., Tefferi, A. & Litzow, M.R. (2001) Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplantation, 28, 951956.
  • Le Dieu, R., Taussig, D.C., Ramsay, A.G., Mitter, R., Miraki-Moud, F., Fatah, R., Lee, A.M., Lister, T.A. & Gribben, J.G. (2009) Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood, 114, 39093916.
  • Lim, Z.Y., Pearce, L., Ho, A.Y., Barber, L., Ingram, W., Usai, M., Tobal, K., Devereux, S., Pagliuca, A. & Mufti, G.J. (2007) Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes. British Journal of Haematology, 138, 517526.
  • Matthews, K., Lim, Z., Afzali, B., Pearce, L., Abdallah, A., Kordasti, S., Pagliuca, A., Lombardi, G., Madrigal, J.A., Mufti, G.J. & Barber, L.D. (2009) Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Haematologica, 94, 956966.
  • Mattsson, J., Uzunel, M., Brune, M., Hentschke, P., Barkholt, L., Stierner, U., Aschan, J. & Ringden, O. (2001) Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation. British Journal of Haematology, 115, 935944.
  • McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., Torok-Storb, B., Yu, C., Blume, K.G. & Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 33903400.
  • Melenhorst, J.J., Scheinberg, P., Chattopadhyay, P.K., Gostick, E., Ladell, K., Roederer, M., Hensel, N.F., Douek, D.C., Barrett, A.J. & Price, D.A. (2009) High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow. Blood, 113, 22382244.
  • Mohty, M., Avinens, O., Faucher, C., Viens, P., Blaise, D. & Eliaou, J.F. (2007) Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. Haematologica, 92, 10041006.
  • Molldrem, J.J., Lee, P.P., Wang, C., Felio, K., Kantarjian, H.M., Champlin, R.E. & Davis, M.M. (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nature Medicine, 6, 10181023.
  • Montero, A., Savani, B.N., Kurlander, R., Read, E.J., Leitman, S.F., Childs, R., Solomon, S.R. & Barrett, A.J. (2005) Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. British Journal of Haematology, 130, 733739.
  • Nadal, E., Garin, M., Kaeda, J., Apperley, J., Lechler, R. & Dazzi, F. (2007) Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia, 21, 472479.
  • Peggs, K.S., Thomson, K., Hart, D.P., Geary, J., Morris, E.C., Yong, K., Goldstone, A.H., Linch, D.C. & Mackinnon, S. (2004) Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood, 103, 15481556.
  • Powles, R., Singhal, S., Treleaven, J., Kulkarni, S., Horton, C. & Mehta, J. (1998) Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood, 91, 34813486.
  • Reddy, V., Iturraspe, J.A., Tzolas, A.C., Meier-Kriesche, H.U., Schold, J. & Wingard, J.R. (2004) Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood, 103, 43304335.
  • Reddy, P., Maeda, Y., Liu, C., Krijanovski, O.I., Korngold, R. & Ferrara, J.L. (2005) A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nature Medicine, 11, 12441249.
  • Rezvani, K., Grube, M., Brenchley, J.M., Sconocchia, G., Fujiwara, H., Price, D.A., Gostick, E., Yamada, K., Melenhorst, J., Childs, R., Hensel, N., Douek, D.C. & Barrett, A.J. (2003) Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood, 102, 28922900.
  • Savani, B.N., Mielke, S., Rezvani, K., Montero, A., Yong, A.S., Wish, L., Superata, J., Kurlander, R., Singh, A., Childs, R. & Barrett, A.J. (2007) Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 12161223.
  • Schmid, C., Schleuning, M., Schwerdtfeger, R., Hertenstein, B., Mischak-Weissinger, E., Bunjes, D., Harsdorf, S.V., Scheid, C., Holtick, U., Greinix, H., Keil, F., Schneider, B., Sandherr, M., Bug, G., Tischer, J., Ledderose, G., Hallek, M., Hiddemann, W. & Kolb, H.J. (2006) Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood, 108, 10921099.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756763.
  • Sykes, M., Szot, G.L., Swenson, K.A. & Pearson, D.A. (1997) Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nature Medicine, 3, 783787.
  • Talarn, C., Urbano-Ispizua, A., Martino, R., Perez-Simon, J.A., Batlle, M., Herrera, C., Granell, M., Gaya, A., Torrebadell, M., Fernandez-Aviles, F., Aymerich, M., Marin, P., Sierra, J. & Montserrat, E. (2007) Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome. Haematologica, 92, 16551663.
  • Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J.W., Pascual, V., Palucka, A.K. & Banchereau, J. (2007) Dendritic cell subsets in health and disease. Immunological Reviews, 219, 118142.